Specifics of the perioperative management of the patients undergoing surgery for malignant neoplasms during the COVID-19 pandemic
Background: The worse prognosis in cancer patients with COVID-19 infection in the context of the pandemic, compared to that in the general population, poses new challenges to ensure the perioperative safety.Aim: To reduce the risk of infection for cancer patients in the perioperative period and to prevent severe COVID-19.Materials and methods: During two months of the COVID-19 (from March to April 2020), we performed 158 surgical interventions: 49 for breast cancer, 31 for lung cancer (videothoracoscopic segmental and lobar resections), 12 for stomach cancer (8 distal and 1 proximal laparoscopic subtotal gastric resections, 3 gastrectomies), 16 laparoscopic resections for colorectal cancer, 29 resections with a reconstructive plastic for malignant skin tumors, 21 palliative and diagnostic operations (diagnostic thoracoscopy and laparoscopy, laparoscopic colostomy).Results: Preventive administration during preparation for surgery (interferon-al-pha2b and low molecular weight heparins) and for suspected infection (antibiotics, low molecular weight heparins and dexamethasone 12 mg/day intravenously) allowed for lower rates of the new coronavirus infection (1.3%) and its severe cases (0%) during surgical treatment of malignant tumors.Conclusion: Surgical treatment of cancer patients in the context of a new coronavirus infection pandemic should be carried out with strict adherence to anti-epidemic measures..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:48 |
|---|---|
| Enthalten in: |
Alʹmanah Kliničeskoj Mediciny - 48(2020), 0, Seite 68-72 |
| Sprache: |
Russisch |
|---|
| Beteiligte Personen: |
A. S. Allakhverdyan [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
|---|
| doi: |
10.18786/2072-0505-2020-48-035 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ006059414 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ006059414 | ||
| 003 | DE-627 | ||
| 005 | 20230309195434.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230225s2020 xx |||||o 00| ||rus c | ||
| 024 | 7 | |a 10.18786/2072-0505-2020-48-035 |2 doi | |
| 035 | |a (DE-627)DOAJ006059414 | ||
| 035 | |a (DE-599)DOAJ4c015e5183f742ae9a8c6a9185dd5f7d | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 100 | 0 | |a A. S. Allakhverdyan |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Specifics of the perioperative management of the patients undergoing surgery for malignant neoplasms during the COVID-19 pandemic |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Background: The worse prognosis in cancer patients with COVID-19 infection in the context of the pandemic, compared to that in the general population, poses new challenges to ensure the perioperative safety.Aim: To reduce the risk of infection for cancer patients in the perioperative period and to prevent severe COVID-19.Materials and methods: During two months of the COVID-19 (from March to April 2020), we performed 158 surgical interventions: 49 for breast cancer, 31 for lung cancer (videothoracoscopic segmental and lobar resections), 12 for stomach cancer (8 distal and 1 proximal laparoscopic subtotal gastric resections, 3 gastrectomies), 16 laparoscopic resections for colorectal cancer, 29 resections with a reconstructive plastic for malignant skin tumors, 21 palliative and diagnostic operations (diagnostic thoracoscopy and laparoscopy, laparoscopic colostomy).Results: Preventive administration during preparation for surgery (interferon-al-pha2b and low molecular weight heparins) and for suspected infection (antibiotics, low molecular weight heparins and dexamethasone 12 mg/day intravenously) allowed for lower rates of the new coronavirus infection (1.3%) and its severe cases (0%) during surgical treatment of malignant tumors.Conclusion: Surgical treatment of cancer patients in the context of a new coronavirus infection pandemic should be carried out with strict adherence to anti-epidemic measures. | ||
| 650 | 4 | |a cancer | |
| 650 | 4 | |a surgical treatment | |
| 650 | 4 | |a covid-19 | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 700 | 0 | |a A. N. Anipchenko |e verfasserin |4 aut | |
| 700 | 0 | |a N. N. Anipchenko |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Alʹmanah Kliničeskoj Mediciny |d MONIKI, 2017 |g 48(2020), 0, Seite 68-72 |w (DE-627)DOAJ000095338 |x 25879294 |7 nnns |
| 773 | 1 | 8 | |g volume:48 |g year:2020 |g number:0 |g pages:68-72 |
| 856 | 4 | 0 | |u https://doi.org/10.18786/2072-0505-2020-48-035 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/4c015e5183f742ae9a8c6a9185dd5f7d |z kostenfrei |
| 856 | 4 | 0 | |u https://www.almclinmed.ru/jour/article/view/1337 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2072-0505 |y Journal toc |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2587-9294 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 48 |j 2020 |e 0 |h 68-72 | ||